Skip to main content
. 2022 Jun 21;36(7):681–702. doi: 10.1007/s40263-022-00931-3
Post-COVID-19 depressive symptoms have been reported in around 35% of patients at short, medium, and long-term follow-up after infection.
The psychopathological mechanisms of post-COVID-19 depressive symptoms are mainly related to the peripheral immune-inflammatory response triggered by the viral infection.
Conventional antidepressants have proved to be effective in treating post-COVID-19 depression.